|
Denis Hanley is a qualified accountant and company director with more than 35 years experience in the management of technology-based growth businesses. He joined the Pharmaxis Board in 2001.
Denis spent 14 years with Baxter International Inc., a global medical products and services company. His career at Baxter included a number of international assignments including its Chicago headquarters and his last position was managing director of Baxter's Australian operations.
In 1983 Denis was founding chief executive officer and in 1986 executive chairman of the Australian-based separations technology company Memtec Ltd (ASX MET). Under his leadership Memtec grew into a NYSE listed (MET) global operating filtration and separations business with 1700 employees.
Since the sale of Memtec to US Filter in 1997 Denis has been a successful angel investor focussing on assisting the commercialisation of several Australian technologies. He is non-executive chairman of CathRx Ltd (ASX CXD) and Lochard Ltd and a non-executive director of Universal Biosensors Inc.
Denis holds an MBA with High Distinction from Harvard Graduate School of Business where he was named a Baker Scholar. | 